Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Succesfuld behandling af svær dabigatranoverdosering med idarucizumab hos en patient med nyresvigt

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The risks of selective serotonin reuptake inhibitor intake in pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hjernerystelse skal tages alvorligt

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Assessment and treatment of cognitive impairments in patients with affective disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Chimeric antigen receptor-T-cellebehandling

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Collagen turnover profiles in chronic kidney disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Pantoprazole in ICU patients at risk for gastrointestinal bleeding-1-year mortality in the SUP-ICU trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Low Incidence of Biphasic Allergic Reactions in Patients Admitted to Intensive Care after Anaphylaxis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mortality in critical illness: The impact of asymmetric dimethylarginine on survival-A systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In the course of an uncomplicated sigmoidostomy a 63-year-old male who had severe comorbidity developed a critical bleeding due to dabigatran intoxication induced by acute kidney injury. Massive blood transfusions, tranexamic acid, Octaplex and haemodialysis were not effective. Administration of idarucizumab induced immediate clinical and paraclinical improvement. Dabigatran should be carefully administrated in patients who have any degree of renal insufficiency. Idarucizumab may be effective in severe bleeding caused by dabigatran.

Translated title of the contributionSuccessful treatment of severe dabigatran intoxication with idarucizumab in a patient with acute kidney injury
Original languageDanish
Article numberV08160562
JournalUgeskrift for Laeger
Volume179
Issue number7
ISSN0041-5782
Publication statusPublished - 2017

    Research areas

  • English Abstract, Journal Article

ID: 50680734